top of page
Search

Massachusetts Overdose Deaths Are Falling. The Addiction Crisis Is Not Over.

Published: July 28, 2026By: Up & At Em Community Initiative

Category: Massachusetts Community Issues | Addiction and Recovery



Fewer people are dying from opioid overdoses in Massachusetts.

That is real progress.


It is not the same as saying fewer people need help.


The latest state estimate puts opioid-related overdose deaths in 2025 below 1,000 for the first time in more than a decade—a 27% decline from 2024. Boston separately reported 120 opioid overdose deaths in 2025, its lowest number in a decade and 56% below the city’s 2023 peak.


Those numbers deserve attention. They represent hundreds of people who may still be alive, families spared an irreversible loss and public-health strategies showing measurable results.


But a lower death count cannot tell us how many residents survived an overdose, waited for a treatment opening, returned to an unsafe drug supply, left detox without stable housing or tried to rebuild while carrying untreated trauma, unemployment and debt.

Massachusetts should recognize the progress without lowering its guard. The next phase of the response must be measured not only by who survives, but by who can get into care, remain in recovery and regain a stable place in the community.



What the latest Massachusetts overdose data show

The state’s 2025 estimate marks a sharp change from the losses recorded only a few years ago. According to the Massachusetts Department of Public Health, opioid-related overdose deaths fell an estimated 27% from 2024 and dropped below 1,000 for the first time since 2013.


The final 2024 report provides useful context. Massachusetts recorded 1,667 drug overdose deaths that year. Of those deaths, 1,336—about 80%—involved opioids.

Boston’s preliminary 2025 data show an even clearer two-year decline:

  • 120 opioid overdose deaths in 2025

  • 29% fewer than in 2024

  • 56% fewer than the 2023 peak of 272 deaths


The Boston Public Health Commission reports that the city distributed nearly 35,000 doses of naloxone in 2025, the largest annual distribution in city history. Community grants also connected nearly 2,000 people with treatment and related services, trained 760 residents in overdose prevention and distributed another 5,100 naloxone doses through funded organizations.


These are not abstract program totals. They show what happens when overdose prevention is moved closer to the people most likely to need it.


Why deaths may be falling

No single program can credibly take credit for a statewide decline. Overdose trends are shaped by the drug supply, treatment access, individual behavior, emergency response, public policy and local outreach. Recent data are also preliminary and can change as records are completed.


Still, Massachusetts and Boston officials point to several strategies operating at the same time:

  • Wider access to naloxone, the medication that can reverse an opioid overdose

  • Street outreach and harm-reduction services

  • Connections to withdrawal management, medication and outpatient treatment

  • Drug checking for fentanyl and xylazine

  • Community-led work in neighborhoods with high overdose rates

  • Housing, workforce and clinical supports funded in part through opioid settlements


Boston’s experience is especially instructive. The city did not treat addiction as one narrow medical issue. Its stated approach includes harm reduction, housing, workforce development, clinical care and evidence-based treatment.


That is closer to the reality residents face. A person can need medication for opioid use disorder and a safe bed. They can need counseling and a state identification card. They can be ready for work and still lack transportation. Treating one barrier while ignoring the others can leave recovery vulnerable.


A lower death total does not mean a lower level of need

Fatal-overdose data answer one urgent question: How many lives were lost?


They do not answer several others:

  • How many nonfatal overdoses occurred?

  • How many people wanted treatment but could not enter it when they were ready?

  • How many completed withdrawal management and had nowhere stable to go next?

  • How many stopped treatment because of transportation, work, child care or insurance problems?

  • How many people are using opioids together with stimulants or other substances?

  • How many families are supporting someone with a substance use disorder without guidance?


Survival is the first outcome. It cannot be the last one.


Naloxone is essential, but it is an emergency intervention—not addiction treatment. Withdrawal management can stabilize someone through the immediate physical effects of stopping a substance, but it is not a complete recovery plan by itself. For opioid use disorder, evidence-based care may include medications such as buprenorphine, methadone or naltrexone, along with counseling, peer support and other services suited to the individual.


The practical challenge is continuity: getting from the emergency department or an overdose reversal to assessment, from assessment to care, and from short-term care to a stable recovery environment without long breaks between steps.


The drug supply remains unpredictable

The illicit drug supply has changed faster than many public systems.

A Massachusetts study of overdose deaths from 2020 through 2023 found fentanyl present in 84.3% of cases and cocaine in 46.1%. Those figures cover an earlier period and should not be presented as a precise picture of the 2025 supply. They do show why the crisis can no longer be understood as exposure to one substance at a time.

People may not know everything contained in what they use. Fentanyl, stimulants, sedatives and other substances can appear in combinations that complicate overdose response and treatment. Drug checking, naloxone access and accurate public information remain important even while the number of deaths declines.

The message should be direct: a better statewide total does not make the current supply safe.


Recovery requires more than detox

“Find a detox bed” is often treated as the entire answer. For many people, withdrawal management is only the opening step.


Longer-term stability can depend on whether someone can move through a full sequence of care and support:

  1. Immediate safety and overdose prevention

  2. Clinical assessment

  3. Withdrawal management when medically appropriate

  4. Medication or other evidence-based treatment

  5. Residential or outpatient care based on individual need

  6. Peer and community recovery support

  7. Safe housing

  8. Employment, education and help with essential documents or benefits


Not everyone needs the same services or the same order. The point is that recovery rarely fits inside one appointment or one program.


Massachusetts has treatment providers, peer recovery support centers, Community Behavioral Health Centers and recovery residences. Availability, eligibility and fit can vary. The resident who needs help still has to find the right door, understand the requirements and keep moving when the first option is full or inappropriate.

That navigation burden is often placed on a person at the moment they have the least time, energy and stability to manage it.


Housing is part of the recovery equation

Housing and addiction are separate issues, but they frequently collide.

A person leaving treatment may return to an environment where drugs are present. Someone without a stable address may struggle to store medication, attend regular appointments, sleep safely or maintain employment. A resident may be technically housed but still face eviction, unsafe conditions or an arrangement that undermines recovery.


This is why Boston residents affected by the opioid crisis identified housing alongside treatment, overdose prevention, workforce development and direct support when advising the city on opioid-settlement priorities. It is also why the city includes housing in its overdose response.


Stable housing does not treat a substance use disorder by itself. Treatment does not erase a housing crisis. But when these systems operate as though the other problem does not exist, residents are left to bridge the gap alone.


Recovery housing can be one option for some people. It should be evaluated carefully for certification, rules, cost, medication policies, accessibility, safety and whether the level of structure matches the person’s needs. A referral is not the same as an endorsement, and no single housing model is right for everyone.


Progress has not been equal across communities

Boston’s overall decline includes meaningful improvement among Black residents. The city reports that fatal overdoses among Black residents declined by an average of 65% across 2024 and 2025 compared with 2023. A 2026 Boston Public Health Commission report also describes a sharp 2024 decline among Black men following focused, collaborative efforts.


The disparity has not disappeared.

Black and Latino residents make up nearly 37% of Boston’s population but accounted for about 48% of overdose deaths in 2025. The city says continued community-informed interventions are needed.


That distinction matters. An improving average can conceal who is still carrying more risk. Effective outreach must be designed with affected communities, located where residents can use it and delivered without stigma. Treatment access on paper is not the same as access that feels safe, timely and workable.


What Massachusetts should measure next

Deaths will remain a critical measure. They should not be the only public scorecard.

A stronger picture of recovery access would also track:

  • Nonfatal overdoses and repeat overdoses

  • Time from a request for help to treatment entry

  • Treatment continuation after 30, 90 and 180 days

  • Follow-up after emergency care or withdrawal management

  • Access to medications for opioid use disorder

  • Housing status when someone enters and leaves treatment

  • Racial, geographic, disability and language disparities

  • Employment, education and benefits connections during recovery

  • The reasons residents are turned away, transferred or lost between programs


These measures ask a harder question than whether a referral was made: did the person actually reach useful support?


Where Massachusetts residents can look for help

If an overdose may be happening, seek emergency medical help immediately and give naloxone if it is available.


For non-emergency resource navigation:


Program openings, eligibility and insurance rules can change. Confirm details directly with a licensed provider. For sober or recovery housing, ask about current certification, all fees, house rules, medication policies and discharge procedures before agreeing to a placement.



How Up & At Em Community Initiative can help

Up & At Em Community Initiative is being developed to make the search for help less fragmented.


We connect Massachusetts residents with information and possible next steps involving detox and substance use treatment, recovery support, sober living, shelters, transitional housing, food assistance, job training, college assistance and other community resources.


We do not guarantee admission, funding, eligibility or placement. Those decisions belong to the individual programs and agencies involved. Our role is to help residents identify options, understand what to ask and move toward the next appropriate contact.

To request help, visit the Up & At Em Community Initiative website and complete the short intake form.



Frequently asked questions

Are opioid overdose deaths declining in Massachusetts?

Yes. Massachusetts estimates that opioid-related overdose deaths in 2025 were 27% lower than in 2024 and fell below 1,000 for the first time in more than a decade. Because the 2025 figure is an estimate, it may be revised as data are finalized.



Does that mean the opioid crisis is over?

No. The decline measures fatal opioid overdoses. It does not count every nonfatal overdose, every person living with a substance use disorder or every resident unable to reach treatment, housing and recovery support.



Where can someone find addiction treatment in Massachusetts?

Residents can search FindTreatment.gov and review resources from the Massachusetts Bureau of Substance Addiction Services. Treatment needs vary, so a clinical assessment can help determine an appropriate level of care.



What is naloxone?

Naloxone is a medication that can temporarily reverse an opioid overdose. It does not create a high and it does not treat opioid use disorder. Emergency medical care is still necessary after it is administered.



Is detox the same as addiction treatment?

No. Withdrawal management, often called detox, addresses the immediate process of stopping substance use when that level of care is appropriate. Ongoing treatment and recovery support may include medication, counseling, outpatient or residential care, peer support and help with housing or employment.



Can Up & At Em guarantee a treatment or sober-living placement?

No. Up & At Em can help identify resources and possible next steps, but it cannot guarantee a program opening, eligibility, funding or placement.



The bottom line

Fewer overdose deaths is the outcome Massachusetts needed.

The next test is whether people who survive can reach treatment, housing and recovery support before the next crisis.

That work is less visible than a headline and harder to summarize in one number. It is also where long-term progress will be decided.



Sources


Editorial note: State and city figures for 2025 are preliminary or estimated and may be revised. This article provides general information, not medical advice or a guarantee of services.

 
 
 

Comments

bottom of page